Cargando…
Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients
Glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists have been approved for the treatment of type 2 diabetes mellitus (T2DM); however, the brain actions of these drugs are not properly established. We used post mortem microdissected human hypothalamic samples for RT-qPCR and Western blotting....
Autores principales: | Renner, Éva, Dóra, Fanni, Oszwald, Erzsébet, Dobolyi, Árpád, Palkovits, Miklós |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781792/ https://www.ncbi.nlm.nih.gov/pubmed/36555587 http://dx.doi.org/10.3390/ijms232415945 |
Ejemplares similares
-
Transcriptome Profiling of the Dorsomedial Prefrontal Cortex in Suicide Victims
por: Dóra, Fanni, et al.
Publicado: (2022) -
Glucagon-like peptide 1 receptor-mediated stimulation of a GABAergic projection from the bed nucleus of the stria terminalis to the hypothalamic paraventricular nucleus
por: Povysheva, Nadya, et al.
Publicado: (2021) -
Distinct Hypothalamic Paraventricular Nucleus Inputs to the Cingulate Cortex and Paraventricular Thalamic Nucleus Modulate Anxiety and Arousal
por: Liu, Ying, et al.
Publicado: (2022) -
Organotypic slice culture of the hypothalamic paraventricular nucleus of rat
por: Cho, Eun Seong, et al.
Publicado: (2007) -
Electrophysiological Effects of Ghrelin in the Hypothalamic Paraventricular Nucleus Neurons
por: dos-Santos, Raoni C., et al.
Publicado: (2018)